These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. A long-term study of prognosis in monoclonal gammopathy of undetermined significance. Kyle RA, Therneau TM, Rajkumar SV, Offord JR, Larson DR, Plevak MF, Melton LJ. N Engl J Med; 2002 Feb 21; 346(8):564-9. PubMed ID: 11856795 [Abstract] [Full Text] [Related]
4. Malignant transformation in IgM monoclonal gammopathy of undetermined significance. Montoto S, Rozman M, Rosiñol L, Nadal E, Giné E, Aymerich M, Ferrer A, Esteve J, Bosch F, López-Guillermo A, Bladé J, Montserrat E. Semin Oncol; 2003 Apr 21; 30(2):178-81. PubMed ID: 12720132 [Abstract] [Full Text] [Related]
5. Predictive variables for malignant transformation in 452 patients with asymptomatic IgM monoclonal gammopathy. Morra E, Cesana C, Klersy C, Varettoni M, Cavanna L, Canesi B, Tresoldi E, Barbarano L, Lazzarino M, Hematology/Oncology Studies and Trials (HOST) Group, Italy. Semin Oncol; 2003 Apr 21; 30(2):172-7. PubMed ID: 12720131 [Abstract] [Full Text] [Related]
6. IgM monoclonal gammopathy of undetermined significance (MGUS) and smoldering Waldenström's macroglobulinemia (SWM). Kyle RA, Dispenzieri A, Kumar S, Larson D, Therneau T, Rajkumar SV. Clin Lymphoma Myeloma Leuk; 2011 Feb 21; 11(1):74-6. PubMed ID: 21454195 [Abstract] [Full Text] [Related]
7. Immunoglobulin M monoclonal gammopathies of undetermined significance and indolent Waldenstrom's macroglobulinemia recognize the same determinants of evolution into symptomatic lymphoid disorders: proposal for a common prognostic scoring system. Baldini L, Goldaniga M, Guffanti A, Broglia C, Cortelazzo S, Rossi A, Morra E, Colombi M, Callea V, Pogliani E, Ilariucci F, Luminari S, Morel P, Merlini G, Gobbi P. J Clin Oncol; 2005 Jul 20; 23(21):4662-8. PubMed ID: 16034042 [Abstract] [Full Text] [Related]
8. Prognostic validation of the international classification of immunoglobulin M gammopathies: a survival advantage for patients with immunoglobulin M monoclonal gammopathy of undetermined significance? Gobbi PG, Baldini L, Broglia C, Goldaniga M, Comelli M, Morel P, Morra E, Cortelazzo S, Bettini R, Merlini G. Clin Cancer Res; 2005 Mar 01; 11(5):1786-90. PubMed ID: 15756000 [Abstract] [Full Text] [Related]
9. Monoclonal gammopathies of undetermined significance. Kyle RA, Rajkumar SV. Best Pract Res Clin Haematol; 2005 Mar 01; 18(4):689-707. PubMed ID: 16026745 [Abstract] [Full Text] [Related]
10. Waldenström macroglobulinaemia and IgM monoclonal gammopathy of undetermined significance: emerging understanding of a potential precursor condition. McMaster ML, Caporaso N. Br J Haematol; 2007 Dec 01; 139(5):663-71. PubMed ID: 18021080 [Abstract] [Full Text] [Related]
11. Detection of MYD88 L265P and WHIM-like CXCR4 mutation in patients with IgM monoclonal gammopathy related disease. Cao XX, Meng Q, Cai H, He TH, Zhang CL, Su W, Sun J, Li Y, Xu W, Zhou DB, Li J. Ann Hematol; 2017 Jun 01; 96(6):971-976. PubMed ID: 28280994 [Abstract] [Full Text] [Related]
12. IgM monoclonal gammopathy of undetermined significance and smoldering Waldenström's macroglobulinemia. Kyle RA, Benson J, Larson D, Therneau T, Dispenzieri A, Melton Iii LJ, Rajkumar SV. Clin Lymphoma Myeloma; 2009 Mar 01; 9(1):17-8. PubMed ID: 19362962 [Abstract] [Full Text] [Related]
13. Clinical characteristics and factors predicting evolution of asymptomatic IgM monoclonal gammopathies and IgM-related disorders. Morra E, Cesana C, Klersy C, Barbarano L, Varettoni M, Cavanna L, Canesi B, Tresoldi E, Miqueleiz S, Bernuzzi P, Nosari AM, Lazzarino M. Leukemia; 2004 Sep 01; 18(9):1512-7. PubMed ID: 15322559 [Abstract] [Full Text] [Related]
14. Immunoglobulin heavy chain sequence analysis in Waldenstrom's macroglobulinemia and immunoglobulin M monoclonal gammopathy of undetermined significance. Rollett RA, Wilkinson EJ, Gonzalez D, Fenton JA, Short MA, Evans PA, Rawstron AC, Owen RG. Clin Lymphoma Myeloma; 2006 Jul 01; 7(1):70-2. PubMed ID: 16879773 [Abstract] [Full Text] [Related]
15. 6q deletion discriminates Waldenström macroglobulinemia from IgM monoclonal gammopathy of undetermined significance. Schop RF, Van Wier SA, Xu R, Ghobrial I, Ahmann GJ, Greipp PR, Kyle RA, Dispenzieri A, Lacy MQ, Rajkumar SV, Gertz MA, Fonseca R. Cancer Genet Cytogenet; 2006 Sep 01; 169(2):150-3. PubMed ID: 16938573 [Abstract] [Full Text] [Related]
16. Prognostic factors and predictors of outcome of immunoglobulin M monoclonal gammopathy of undetermined significance. Kyle RA, Rajkumar SV, Therneau TM, Larson DR, Plevak MF, Melton LJ. Clin Lymphoma; 2005 Mar 01; 5(4):257-60. PubMed ID: 15794860 [Abstract] [Full Text] [Related]
19. Long-term follow-up of a population based cohort with monoclonal proteinaemia. Schaar CG, le Cessie S, Snijder S, Franck PF, Wijermans PW, Ong C, Kluin-Nelemans H. Br J Haematol; 2009 Jan 01; 144(2):176-84. PubMed ID: 19036113 [Abstract] [Full Text] [Related]